Gene expression signature for angiogenic and nonangiogenic non-small-cell lung cancer
- 13 December 2004
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 24 (7) , 1212-1219
- https://doi.org/10.1038/sj.onc.1208242
Abstract
Angiogenesis is regarded as essential for tumour growth. However, we have demonstrated that some other aggressive non-small-cell lung carcinomas (n-SCLC) do not have angiogenesis. In this study, using cDNA microarray analysis, we demonstrate that angiogenic and nonangiogenic tumour types can be distinguished by their gene expression profiles. Tissue samples from 42 n-SCLC patients were obtained with consent. In all, 12 tumours were nonangiogenic and 30 angiogenic. The two groups were matched by age, sex, smoking and tumour stage. Total RNAs were extracted followed by microarray hybridization and image scan procedure. Data were analysed using GeneSpring 5.1 software. A total of 62 genes were found to be able to separate angiogenic from nonangiogenic tumours. Nonangiogenic tumours have higher levels of genes concerned with mitochondrial metabolism, mRNA transcription, protein synthesis and the cell cycle. Angiogenic tumours have higher levels of genes coding for membrane vesicles, integrins, remodelling, angiogenesis and apoptosis. These results further support our first finding that nonangiogenic lung tumours are fast-growing tumours filling the alveoli in the absence of vascular remodelling. We raise the hypothesis that in nonangiogenic tumours, hypoxia leads to a higher activation of the mitochondrial respiratory chain, which allows tumour growth without triggering angiogenesis.Keywords
This publication has 17 references indexed in Scilit:
- Clinical translation of angiogenesis inhibitorsNature Reviews Cancer, 2002
- Integrin (α6β4) regulation of eIF-4E activity and VEGF translationThe Journal of cell biology, 2002
- Transmission of cell stress from endoplasmic reticulum to mitochondriaThe Journal of cell biology, 2002
- Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium–derived factorNature Medicine, 2002
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002
- Tumor Angiogenesis Induced by Granulocyte Chemotactic Protein-2 as a Countercurrent PrincipleThe American Journal of Pathology, 2001
- Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGFScience, 1999
- The Human LON Protease Binds to Mitochondrial Promoters in a Single-Stranded, Site-Specific, Strand-Specific MannerBiochemistry, 1998
- Angiogenesis in primary lung cancer and lung secondariesEuropean Journal Of Cancer, 1996
- Junctional Epidermolysis Bullosis: Defects in Expression of Epiligrin/Nicein/Kalinin and Integrin beta4 That Inhibit Hemidesmosome Formation.Journal of Investigative Dermatology, 1994